Product Image

Contributor Information

  • Name Dr. Francisco RuĂ­z-Cabello Osuna,Dr. Miguel Ángel LĂłpez-Nevot and Federico Garrido Torres-Puchol,
  • Institute Virgen de las Nieves University Hospital, The Andalusian Health Service
  • Primary citation Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783

Tool Details

  • Tool name: Anti-B2M monoclonal antibody [GRH1]
  • Clone: GRH1
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Reactivity: Human
  • Host: Mouse
  • Cancer type: Blood cancer
  • Molecular weight of the target: 12 kDa
  • Application: FACS; IHC; ELISA; WB
  • Description: Beta-2-microglobulin (B2M) is part of the histocompatibility antigens class I, HLA-ABC, forming a non-covalently bound complex with them. It is expressed in most cells in the body, with very low or undetectable levels in neurons and spermatozoa.
  • Immunogen: B-ALL cells
  • Isotype: IgG1
  • Research area: Cancer

  • For Research Use Only

Target Details

  • Target: Beta-2-microglobulin
  • Target alternate names: B2M
  • Target molecular weight: 12 kDa

Application Details

  • Application: FACS; IHC; ELISA; WB

Handling

  • Storage buffer: PBS with 0.02% azide
  • Storage conditions:  -15°C to -25°C
  • Shipping conditions: 4°C

Documentation

References

  •   Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783
  •   B del Campo. 2014. Int J Cancer. 134(1):102-113. PMID: 23784959